Civic Intelligence

Peptide Therapeutics Foundation

990EZ • Fiscal year 2019 • EIN 26-3728931

Jan 01, 2019 to Dec 31, 2019 • Filed on Feb 20, 2020

4245 Sorrento Valley BlvdSan Diego, CA 92121

(858) 657-1511

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

58th percentile

0.00x

Higher debt load relative to assets than 58% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Liabilities / Revenue

61st percentile

0.00x

Higher debt load relative to revenue than 61% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Net Margin

61st percentile

8.6%

Higher net margin than 61% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Top Officer Pay

77th percentile

$0

Higher top officer pay than 77% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Asset Growth

50th percentile

2.2%

Faster asset growth than 50% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Revenue Growth

40th percentile

-5.2%

Faster revenue growth than 40% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Assets

Up

$442,929

Up $9,511 (+2.2%) from 2018

Net Assets

Up

$442,498

Up $10,376 (+2.4%) from 2018

Liabilities

Down

$431

Down $865 (-67%) from 2018

Revenue

Down

$121,265

Down $6,713 (-5.2%) from 2018

Expenses

Up

$110,889

Up $4,269 (+4.0%) from 2018

Net Income

Down

$10,376

Down $10,982 (-51%) from 2018

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0Assets 2013: $321,273Liabilities 2013: $47,078Net Assets 2013: $274,1952013Assets 2014: $348,771Liabilities 2014: $49,919Net Assets 2014: $298,8522014Assets 2015: $389,214Liabilities 2015: $58,059Net Assets 2015: $331,1552015Assets 2016: $404,349Liabilities 2016: $58,620Net Assets 2016: $345,7292016Assets 2017: $478,564Liabilities 2017: $67,800Net Assets 2017: $410,7642017Assets 2018: $433,418Liabilities 2018: $1,296Net Assets 2018: $432,1222018Assets 2019: $442,929Liabilities 2019: $431Net Assets 2019: $442,4982019Assets 2020: $442,709Liabilities 2020: $2,807Net Assets 2020: $439,9022020Assets 2021: $373,700Liabilities 2021: $197Net Assets 2021: $373,5032021Assets 2022: $281,743Liabilities 2022: $500Net Assets 2022: $281,2432022Assets 2023: $286,944Net Assets 2023: $286,9442023Assets 2024: $335,263Net Assets 2024: $335,2632024

Highlighted filing

2019

Assets$442,929
Liabilities$431
Net Assets$442,498

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2013: $122,329Expenses 2013: $101,707Net Income 2013: $20,6222013Revenue 2014: $137,675Expenses 2014: $113,018Net Income 2014: $24,6572014Revenue 2015: $142,758Expenses 2015: $110,455Net Income 2015: $32,3032015Revenue 2016: $136,200Expenses 2016: $121,626Net Income 2016: $14,5742016Revenue 2017: $172,574Expenses 2017: $107,539Net Income 2017: $65,0352017Revenue 2018: $127,978Expenses 2018: $106,620Net Income 2018: $21,3582018Revenue 2019: $121,265Expenses 2019: $110,889Net Income 2019: $10,3762019Revenue 2020: $43,680Expenses 2020: $46,276Net Income 2020: -$2,5962020Revenue 2021: $66,103Expenses 2021: $115,909Net Income 2021: -$49,8062021Revenue 2022: $110,022Expenses 2022: $129,463Net Income 2022: -$19,4412022Revenue 2023: $134,883Expenses 2023: $157,903Net Income 2023: -$23,0202023Revenue 2024: $174,477Expenses 2024: $144,680Net Income 2024: $29,7972024

Highlighted filing

2019

Revenue$121,265
Expenses$110,889
Net Income$10,376
Jump To
Filing Snapshot
Filing Period
Jan 1, 2019 to Dec 31, 2019
Signed
Feb 20, 2020
Return Version
2019v5.0
Gross Receipts
$121,265
Mission and Program Overview

Mission

The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.

Program Services

DescriptionGrantsExpenses
HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.-$110,889
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
ADRIENNE DAY PHDSr Director Busi-$0--
SOUMITRA GHOSH PHDPresident-$0--
ROBERT HAGOPIANDirector Busines-$0--
LUTZ JERMUTUSSenior Direc-$0--
FA LIU PHDDirector CHE-$0--
RIE SCHULTZ HANSEN PHDSVP & Chief-$0--
PANKAJ R PATELChairman & D-$0--
RAJIV SHARMARepresentati-$0--
Filing and Contact Details

Filer

Filer Name
Peptide Therapeutics Foundation
EIN
26-3728931
Phone
8586571511
Address
4245 SORRENTO VALLEY BLVD, SAN DIEGO, CA 92121

Signing Officer

Name
Adrienne Day Phd
Title
Sr Director Business Dev
Phone
8586571511
Signed
2020-02-20

Preparer

Firm
GOODSELL & COMPANY INC CPA'S
Address
2665 4TH AVE, SAN DIEGO, CA 92103-6514
Preparer
Steven J Holc CPA
Phone
6192384343
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses symposium expenses 103,722 foundation maintenance 5,917 total 109,639

Form 990-ez, Part II, Line 26

Accrued symposium expense 1,296 431

Form 990-ez, Part III

The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.

Form 990-ez, Part III, Line 28

Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, cmos, cros, and investors interested in all aspects of peptide r&d, including drug discovery, safety and toxicology, clinical develoment, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs. The organization also provided 13 postdoctoral fellows and graduate students with free registration to the symposium.

Raw XML Appendix177 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum08586571511
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt04245 SORRENTO VALLEY BLVD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SAN DIEGO
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092121
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0433418
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0442929
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt089945
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt010376
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt01250
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0433418
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0442929
IRS990EZ/GrossReceiptsAmt0121265
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0432122
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0442498
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0432122
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0442498
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt01.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt71.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0ADRIENNE DAY PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1SOUMITRA GHOSH PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2ROBERT HAGOPIAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3LUTZ JERMUTUS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4FA LIU PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5RIE SCHULTZ HANSEN PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6PANKAJ R PATEL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7RAJIV SHARMA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0SR DIR. BUSI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2DIR. BUSINES
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SENIOR DIREC
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4DIRECTOR CHE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5SVP & CHIEF
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6CHAIRMAN & D
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7REPRESENTATI
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt0109639
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.
IRS990EZ/ProgramServiceRevenueAmt031320
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0110889
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt01296
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt0431
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0110889
IRS990EZ/TotalProgramServiceExpensesAmt0110889
IRS990EZ/TotalRevenueAmt0121265
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.PEPTIDETHERAPEUTICS.ORG
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0OTHER INCOME 3,492
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART III, LINE 12
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt089945
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt089970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0134940
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt089940
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt0104970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0509765
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt031320
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt035390
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt037634
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt046260
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt037788
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0188392
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus1YearAmt02618
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus2YearsAmt0874
IRS990ScheduleA/OtherIncome509Grp/TotalAmt03492
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99500
IRS990ScheduleA/PublicSupportPY509Pct00.99510
IRS990ScheduleA/PublicSupportTotal509Amt0698157
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0121265
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0125360
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0172574
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0136200
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0142758
IRS990ScheduleA/Total509Grp/TotalAmt0698157
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0121265
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0127978
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0173448
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0136200
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0142758
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0701649
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES SYMPOSIUM EXPENSES 103,722 FOUNDATION MAINTENANCE 5,917 TOTAL 109,639
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ACCRUED SYMPOSIUM EXPENSE 1,296 431
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART II, LINE 26
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02020-09-23 17:36:50Z
ReturnHeader/BusinessOfficerGrp/PersonNm0ADRIENNE DAY PHD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0SR DIR. BUSINESS DEV
ReturnHeader/BusinessOfficerGrp/PhoneNum08586571511
ReturnHeader/BusinessOfficerGrp/SignatureDt02020-02-20
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PEPTIDE THERAPEUTICS FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0PEPT
ReturnHeader/Filer/EIN0263728931
ReturnHeader/Filer/PhoneNum08586571511
ReturnHeader/Filer/USAddress/AddressLine1Txt04245 SORRENTO VALLEY BLVD
ReturnHeader/Filer/USAddress/CityNm0SAN DIEGO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092121
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId05D07FE3862598DFA09B2BC5D6C67A36B8BA055E7
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId05D07FE3862598DFA09B2BC5D6C67A36B8BA055E7
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt098.171.214.221
ReturnHeader/FilingSecurityInformation/IPDt02020-05-15
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0CD
ReturnHeader/FilingSecurityInformation/IPTm018:18:52
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0331005644
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0GOODSELL & COMPANY INC CPA'S
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt02665 4TH AVE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0SAN DIEGO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0921036514
ReturnHeader/PreparerPersonGrp/PhoneNum06192384343
ReturnHeader/PreparerPersonGrp/PreparationDt02020-05-15
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0STEVEN J HOLC CPA
ReturnHeader/ReturnTs02020-05-15T18:18:52-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02019-01-01
ReturnHeader/TaxPeriodEndDt02019-12-31
ReturnHeader/TaxYr02019

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings